Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Consolidated Net Income: 2010-2021

Historic Consolidated Net Income for Neurocrine Biosciences (NBIX) over the last 12 years, with Sep 2021 value amounting to $22.5 million.

  • Neurocrine Biosciences' Consolidated Net Income rose 139.06% to $22.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $39.3 million, marking a year-over-year decrease of 57.93%. This contributed to the annual value of $37.0 million for FY2019, which is 75.32% up from last year.
  • As of Q3 2021, Neurocrine Biosciences' Consolidated Net Income stood at $22.5 million, which was down 46.81% from $42.3 million recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Consolidated Net Income high stood at $79.6 million for Q2 2020, and its period low was -$102.1 million during Q1 2019.
  • Its 3-year average for Consolidated Net Income is $19.3 million, with a median of $35.7 million in 2019.
  • Per our database at Business Quant, Neurocrine Biosciences' Consolidated Net Income slumped by 293.66% in 2017 and then surged by 967.58% in 2019.
  • Quarterly analysis of 5 years shows Neurocrine Biosciences' Consolidated Net Income stood at $6.9 million in 2017, then spiked by 172.82% to $18.8 million in 2018, then soared by 80.84% to $34.0 million in 2019, then tumbled by 207.06% to -$57.6 million in 2020, then surged by 139.06% to $22.5 million in 2021.
  • Its last three reported values are $22.5 million in Q3 2021, $42.3 million for Q2 2021, and $32.1 million during Q1 2021.